Journal of Virology · 2020 · 56 citations · 25 references
Life SciencesInfectious DiseasesMedicinal ChemistryDrug DiscoveryMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyRna Polymerase StructureViral InfectionsViral StructureViral VaccinesAntiviral Drug DesignAntiviral Structure-activity RelationshipsNon-nucleoside AntiviralsNon-nucleoside InhibitorsNonnucleoside InhibitorsViral Polymerase InhibitorsViral Replication InhibitionViral Replication Inhibitors
genus, which comprises several important human pathogens. There is currently neither an approved vaccine nor antiviral drugs available to prevent infection by ZIKV. The nonstructural protein 5 (NS5) polymerase, which is responsible for replicating the viral RNA genome, represents one of the most promising targets for antiviral drug development. Starting from compounds recently developed against dengue virus NS5, we designed and synthesized inhibitors targeting Zika virus NS5. We show that these novel compounds inhibit viral replication by targeting the polymerase activity. High-resolution X-ray crystallographic structures of protein-inhibitor complexes demonstrated specific binding to an allosteric site within the polymerase, called the N pocket. This work paves the way for the future structure-based design of potent compounds specifically targeting ZIKV RNA polymerase activity.
25
Wolfgang Kabsch · Acta Crystallographica Section D Biological Crystallography · 2010 · 16.9K citations · Full text
Zika Virus Associated with Microcephaly
Jernej Mlakar, Miša Korva, Nataša Tul et al. · New England Journal of Medicine · 2016 · 2.9K citations · Full text
CASTp 3.0: computed atlas of surface topography of proteins
Wei Tian, Chang Chen, Xue Lei et al. · Nucleic Acids Research · 2018 · 2.4K citations · Full text
Linking Crystallographic Model and Data Quality
P. Andrew Karplus, Kay Diederichs · Science · 2012 · 1.8K citations · Full text